Home/Filings/4/0001326110-25-000012
4//SEC Filing

Sachs David C. 4

Accession 0001326110-25-000012

CIK 0001326110other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:16 PM ET

Size

9.0 KB

Accession

0001326110-25-000012

Insider Transaction Report

Form 4
Period: 2025-02-10
Sachs David C.
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2025-02-10+246,710246,710 total
    Common Stock (246,710 underlying)
  • Award

    Stock Option (right to buy)

    2025-02-10+843,750843,750 total
    Exercise: $3.39Exp: 2035-02-10Common Stock (843,750 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. (the "Issuer") common stock.
  • [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025.
  • [F3]Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the option shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the option shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2025.

Issuer

ImmunityBio, Inc.

CIK 0001326110

Entity typeother

Related Parties

1
  • filerCIK 0001848899

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:16 PM ET
Size
9.0 KB